Patton J H, Lyden S P, Ragsdale D N, Croce M A, Fabian T C, Proctor K G
Department of Surgery, University of Tennessee, Memphis, USA.
J Trauma. 1998 May;44(5):750-8; discussion 758-9. doi: 10.1097/00005373-199805000-00002.
Granulocyte colony-stimulating factor (G-CSF) increases production and release of neutrophil precursors and activates multiple functions of circulating polymorphonuclear neutrophils (PMNs). G-CSF has therapeutic effects in many experimental models of sepsis; its actions with superimposed reperfusion insults are unknown. In traumatic conditions, G-CSF could exacerbate unregulated, PMN-dependent injury to otherwise normal host tissue or, it could partially reverse trauma-induced immune suppression, which may improve long-term outcome. This study tested whether stimulating PMN proliferation and function with G-CSF during recovery from trauma+sepsis potentiated reperfusion injury or whether it improved host defense.
Anesthetized swine were subjected to cecal ligation and incision, 35% hemorrhage, and 1 hr of hypotension. Resuscitation consisted of intravenous G-CSF (5 microg/kg) or placebo followed by shed blood and 40 mL/kg of lactated Ringer's solution. The control group received laparotomy only. G-CSF or placebo was given daily. Animals were killed at 4 days. Observers, blind to the protocol, graded autopsy samples for localization of infection and quality of abscess wall formation. Data included complete blood count, granulocyte oxidative burst after phorbol myristate acetate stimulation in vitro (GO2B), bronchoalveolar lavage (BAL) cell count, BAL noncellular protein, lipopolysaccharide-stimulated tumor necrosis factor production in whole blood in vitro (lipopolysaccharide-tumor necrosis factor), and lung tissue myeloperoxidase (MPO).
Neutrophilia and localization of infection, were significantly improved by G-CSF. Variables altered by G-CSF, though not significantly, showed GO2B potential increased by 50%, lipopolysaccharide-tumor necrosis factor decreased by 50%, and improved survival versus placebo (100% vs. 70%). G-CSF did not increase lung MPO, BAL cell count, or BAL protein. Both arterial and venous O2 saturations were unaltered.
Our data show that G-CSF initiated at the time of resuscitation reduced the sequelae of posttrauma sepsis by increasing PMN proliferation and function without potentiating PMN-mediated lung reperfusion injury.
粒细胞集落刺激因子(G-CSF)可增加中性粒细胞前体的产生和释放,并激活循环中的多形核中性粒细胞(PMN)的多种功能。G-CSF在许多脓毒症实验模型中具有治疗作用;其与叠加的再灌注损伤的相互作用尚不清楚。在创伤情况下,G-CSF可能会加剧PMN对原本正常宿主组织的失控性损伤,或者它可能部分逆转创伤诱导的免疫抑制,这可能改善长期预后。本研究测试了在创伤+脓毒症恢复期间用G-CSF刺激PMN增殖和功能是否会增强再灌注损伤,或者是否会改善宿主防御。
对麻醉的猪进行盲肠结扎和切开、35%出血以及1小时低血压。复苏包括静脉注射G-CSF(5微克/千克)或安慰剂,随后输注 shed blood 和40毫升/千克的乳酸林格氏液。对照组仅接受剖腹手术。每天给予G-CSF或安慰剂。在第4天处死动物。对方案不知情的观察者对尸检样本的感染定位和脓肿壁形成质量进行分级。数据包括全血细胞计数、体外佛波酯肉豆蔻酸酯刺激后粒细胞氧化爆发(GO2B)、支气管肺泡灌洗(BAL)细胞计数、BAL非细胞蛋白、体外全血中脂多糖刺激的肿瘤坏死因子产生(脂多糖-肿瘤坏死因子)以及肺组织髓过氧化物酶(MPO)。
G-CSF显著改善了中性粒细胞增多和感染定位。G-CSF改变的变量虽无显著差异,但显示GO2B潜力增加了50%,脂多糖-肿瘤坏死因子减少了50%,与安慰剂相比生存率提高(100%对70%)。G-CSF未增加肺MPO、BAL细胞计数或BAL蛋白。动脉和静脉血氧饱和度均未改变。
我们的数据表明,复苏时开始使用G-CSF可通过增加PMN增殖和功能来减少创伤后脓毒症的后遗症,而不会增强PMN介导的肺再灌注损伤。